Skip to content

Ayahuasca research published in 2026

Page 5 of 5: studies 81 to 85 of 85, newest first. Back to the ayahuasca overview

Studies

Ayahuasca and Fibromyalgia: Promising Mechanisms, Missing Evidence: A Mini-review

Journal for Transdisciplinary Approach in Complementary and Alternative Medicine 2026 Jozélio Freire de Carvalho

Abstract Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain, fatigue, and cognitive symptoms. Despite current therapeutic strategies, many patients continue to experience the poor outcomes. Ayahuasca, a traditional Amazonian brew containing N, N-dimethyltryptamine (DMT), and β-carboline alkaloids, has shown antinociceptive and anti-inflammatory...

The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study.

Frontiers in Psychiatry 2026 Gláucio Silva Camargos, Geraldo Magela De Faria Júnior, Marcelo Lourenço et al.

This longitudinal observational study evaluated changes in depressive symptoms associated with ritualistic ayahuasca use in patients diagnosed with depressive disorders, as well as depressive burden in individuals with anxiety and substance use disorders. The research was conducted with 280 adults treated at clinics in the northwestern region of the state of São Paulo, under the jurisdiction of...

La responsabilidad penal del guía por los eventuales daños derivados de la ingesta de ayahuasca en el curso de una ceremonia de consumo

Revista de Estudios Jurídicos y Criminológicos 2026 Antonio Martín Pardo

El presente trabajo examina la responsabilidad penal del guía en su- puestos de daños derivados de la ingesta de ayahuasca en el contexto de ceremonias rituales de consumo, las cuales han experimentado un notable auge en los últimos años. A partir del análisis de la contribución de la víctima a su propio daño, se revisan las principales posiciones doctrinales y jurisprudenciales sobre la...

DOI: 10.25267/rejucrim.2026.i13.09 (opens in new tab) Context archaeology Amazon rainforest Work physics Action physics

Psychedelics: Future Therapeutics in Major Depression?

Advances in experimental medicine and biology 2026 Berend Olivier, Jocelien D A Olivier

Major depressive disorder (MDD), including treatment-resistant depression (TRD), is a highly prevalent psychiatric disorder. MDD is associated with severe suffering, burden and large economical costs. Although various conventional antidepressant treatments are available, a large portion of depressed people does not or not adequately respond to the first-line treatments (mostly SSRIs and SNRIs)...